PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis

類似資料

• PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
  著者:: Zholobova, ES, 等
  出版事項: (2013)
• Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
  著者:: Rozvadovskaya OS, 等
  出版事項: (2011-09-01)
• Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
  著者:: Konopelko, OU, 等
  出版事項: (2011)
• Indirect comparison of etanercept and abatacept efficacy and safety in patients with polyarticular juvenile idiopathic arthritis
  著者:: Loskutova (Konopelko), OU, 等
  出版事項: (2014)
• PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
  著者:: Christensen, AE, 等
  出版事項: (2013)